Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

02. November 2022 08:00 ET | Quelle: scPharmaceuticals, Inc.

scPharmaceuticals to Participate in the Jefferies London Healthcare Conference

BURLINGTON, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to...
02. November 2022 08:00 ET | Quelle: iPower, Inc.

iPower Schedules Fiscal First Quarter 2023 Conference Call for November 14, 2022 at 4:30 p.m. ET

DUARTE, Calif., Nov. 02, 2022 (GLOBE NEWSWIRE) -- iPower Inc. (Nasdaq:IPW) (“iPower” or the “Company”), a leading online retailer and supplier of consumer home and garden products, will host a...
02. November 2022 08:00 ET | Quelle: Esperion Therapeutics, Inc.

Esperion to Participate in Jefferies London Healthcare Conference

ANN ARBOR, Mich., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that President and CEO, Sheldon Koenig, will present at the Jefferies London Healthcare Conference on...
02. November 2022 07:55 ET | Quelle: Virtual Investor Conferences

OverActive Media to Webcast Live at VirtualInvestorConferences.com November 3

Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com TORONTO, Nov. 02, 2022 ...
02. November 2022 07:30 ET | Quelle: Kura Oncology, Inc.

Kura Oncology to Participate in Two Upcoming Investor Conferences

SAN DIEGO, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
02. November 2022 07:30 ET | Quelle: Dyne Therapeutics, Inc.

Dyne Therapeutics to Present at Investor Conferences in November

WALTHAM, Mass., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for...
02. November 2022 07:30 ET | Quelle: Sensei Biotherapeutics

Sensei Biotherapeutics to Participate in the 13th Annual Jefferies Global Healthcare Conference

BOSTON, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (NASDAQ: SNSE), an immuno-oncology company focused on the discovery and development of next generation therapeutics for cancer,...
02. November 2022 07:30 ET | Quelle: Rhythm Pharmaceuticals, Inc.

Rhythm Pharmaceuticals Presents Data from Phase 2 and Long-term Extension Trials Evaluating Setmelanotide for the Treatment of Hypothalamic Obesity at ObesityWeek® and Plans to Initiate Phase 3 Trial in Early 2023

-- Phase 3 clinical trial design reflects feedback obtained during recent discussions with FDA -- -- 89 percent (16 of 18) patients achieved primary endpoint with a BMI decrease greater than 5...
02. November 2022 07:29 ET | Quelle: Reliq Health Technologies Inc.

Reliq Health Technologies, Inc. Announces Upcoming Shareholder Update Webinar

HAMILTON, Ontario, Nov. 02, 2022 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global healthcare technology...
02. November 2022 07:05 ET | Quelle: Clearside Biomedical, Inc.

Clearside Biomedical to Report Third Quarter 2022 Financial Results and Provide Corporate Update on Wednesday, November 9, 2022

ALPHARETTA, Ga., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of therapies to the back of the eye through the...

Vorherige Seite

Nächste Seite